Charles River Lunch & Learn
Update on New Humanized & Immunodeficient Oncology Models
by: Srna Vlaho, Scientific & Business Innovation Manager - Charles River
Recent advances in cancer understanding and molecular engineering have transformed oncology research in the last decade. In vivo research models of disease are fundamental tools in understanding the nature of interactions between cancer cells and human immune system and the performance of current therapies.
Presented will be an overview of these technologies and demonstration of the utility of these models in research.
Data will be presented showing the growth of important tumor cell lines and PDX in immunodeficient mouse model platforms and a humanizable mouse model NOD-Prkdcem26Cd52Il2rgem26Cd22 (NCG).
Tuesday, March 17, 2020
12:00pm
McIntyre Room 519
** Lunch (Pizza) and beverages will be provided **
RSVP:
Martin Pronovost - Account Manager
438-405-1749
martin.pronovost [at] crl.com (subject: McGill%20Lunch%20%26%20Learn%20-%20March%2017%2C%202020)
